LCN2 and coronary artery disorder: In recent years, the possible association of serum LCN2 levels and CAD has been addressed by clinical trials, and studies based on Caucasian and Korean populations have suggested positive associations between expression of this multifunctional protein and development of this life-threatening disease with systemic implications [16-18].